An observational study in Coronary Artery Disease, Congestive Heart Failure and Atrial Fibrillation, sponsored by National Heart Centre Singapore. Active, not recruiting at 13 sites in Singapore. Open to participants aged 21 Years to 120 Years. Per ClinicalTrials.gov, last updated 2020-03-24.
Sponsored by National Heart Centre Singapore · Observational
The research project aims to perform data extraction, integration and analysis across multiple clinical, administrative, financial and pharmacy databases in the participating institutions. The key data components will include clinical cardiovascular specific data, procedural data, financial and administrative data (e.g. cost of medications and supplies, length of stay, diagnosis codes etc.), short-to-long term clinical outcomes (including hospital re-admissions, cardiovascular events, death), and quality-of-care indices (e.g. compliance to guideline-recommended therapy and medications). The research project will involve all patients proven and/or suspected with coronary artery disease (CAD), congestive heart failure (CHF) and atrial fibrillation (AF) admitted to National Heart Centre Singapore (NHCS) and NUH.
The research project is initiated by NHCS and its participating institutions include Ministry of Health (MOH), as well as National University Hospital (Singapore) Pte Ltd (NUH), Changi General Hospital (CGH), Khoo Teck Puat Hospital (KTPH), Singapore General Hospital (SGH), Tan Tock Seng Hospital (TTSH), Ng Teng Fong General Hospital (NTFGH) , SingHealth Polyclinics, National Healthcare Group Polyclinics (NHGP), Sengkang Hospital (SKH), National University Polyclinics (NUP), and Alexandra Hospital (AH).
The research project will leverage on the Health Data Grid (HDG) pilot project, now known as Business Research Analytics Insights Network (BRAIN). BRAIN will be a virtual repository that will enable access to anonymised and merged data from disparate databases at multiple institutions. The structures of BRAIN will preserve patients' privacy and confidentiality, ensure IT security and allow access only by authorised persons. The BRAIN pilot project will be co-funded by MOH and the Infocommunication Media Development Authority of Singapore (IMDA). To avoid doubt, after the BRAIN pilot project, a separate approval from the appropriate stakeholders will have to be sought for further funding of the operating costs of the BRAIN, regardless of whether the value of the BRAIN has been demonstrated during the BRAIN pilot project. There is no direct cost involved in the research project.
For the research project, MOH will contribute administrative data from the Registry of Births and Deaths, Casemix \& Subvention, the Mediclaim, and Omnibus databases, and the other participating institutions will contribute the data from the National Electronic Health Records (NEHR), Electronic Health Intelligence System (eHIntS) and Enterprise Data Warehouse (EDW) to BRAIN. Only anonymised data from BRAIN will be utilised for the research project.
5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.
This study's planned enrollment of 7,205,000 is above the median of 200 across 1,679 observational studies indexed under Heart Failure.
Browse Heart Failure studies →National Heart Centre Singapore is the lead sponsor of 61 studies on the registry; 18 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The participating institutions will include National Heart Centre Singapore, National University Heart Centre, Singapore General Hospital, Tan Tock Seng Hospital, Changi General Hospital, Khoo Teck Puat Hospital, Ng Teng Fong General Hospital, Singhealth Polyclinics, National Healthcare Group Polyclinics, Sengkang General Hospital, National University Polyclinics, Alexandra Hospital, and the Ministry of Health Health Services Research Division.
All patients who present to a healthcare institution with either CAD or suspected CAD (including chest pain); CHF or suspected CHF; AF or suspected AF
Exclusion Criteria:
1. Clinical data collected by Singapore Cardiac Data Bank (SCDB) 2. Clinical, administrative, pharmacy, financial data collected by each participating hospital 3. Administrative data collected by the Ministry of Health
Other: Data Collection
1. Clinical data collected by Singapore Cardiac Data Bank (SCDB) 2. Clinical, administrative, pharmacy, financial data collected by each participating hospital 3. Administrative data collected by the Ministry of Health
Other: Data Collection
1. Clinical data collected by Singapore Cardiac Data Bank (SCDB) 2. Clinical, administrative, pharmacy, financial data collected by each participating hospital 3. Administrative data collected by the Ministry of Health
Other: Data Collection
1. Collection of data as detailed below: 1. Clinical data collected by SCDB 2. Clinical, administrative, pharmacy, financial data collected by each participating hospital 3. Administrative data collected by MOH 2. Data will be extracted and anonymized on a secure healthcare analytics platform 3. Collaboration with the MOH for collection of administrative and financial data 4. Analysis on how healthcare behavior is affected by education, socioeconomic level and other social or cultural factors. 5. Statistical Analysis by the bio statistical team. This team will be responsible for collecting and merging the collected data and will also ensure the quality of the data.
The primary outcome measure will be to assess the total number of patients who passed away due to any cause at the 1-year time point
Mortality
Time frame: 1 year
The primary outcome measure will be to assess the total number of patients who passed away due to any cause at the 2-year time point
Mortality
Time frame: 2 year
The primary outcome measure will be to assess the total number of patients who passed away due to any cause at the 3-year time point
Mortality
Time frame: 3 year
The secondary outcome measure will be to assess the total number of patients who had major adverse cardiac event (MACE) due to any cause at the 1-year time point
Myocardial Infarction (MI), Stroke, CHF
Time frame: 1 year
The secondary outcome measure will be to assess the total number of patients who had MACE due to any cause at the 2-year time point
MI, Stroke, CHF
Time frame: 2 year
The secondary outcome measure will be to assess the total number of patients who had MACE due to any cause at the 3-year time point
MI, Stroke, CHF
Time frame: 3 year
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Heart Centre Singapore